News - Page 151 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104

Field Trip Health Ltd. to Pursue Treatment Resistant Depression and Postpartum Depression as Indications for FT-104

Post published:September 9, 2021
Post category:Press Release

Read more about the article Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its Novel Psilocybin-Inspired Clinical Candidate

Mindset Pharma Selects Treatment-Resistant Depression and End of Life Cancer Angst as Indications for MSP-1014, its Novel Psilocybin-Inspired Clinical Candidate

Post published:September 9, 2021
Post category:Press Release

Read more about the article Wesana Health Announces Closing of PsyTech Acquisition

Wesana Health Announces Closing of PsyTech Acquisition

Post published:September 9, 2021
Post category:Press Release

Read more about the article Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

Levitee Labs Commences Trading in U.S. Under Ticker LVTTF

Post published:September 9, 2021
Post category:Press Release

Read more about the article atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression

atai Life Sciences and Introspect Digital Therapeutics to test novel digital therapeutic approach in patients receiving ketamine for treatment resistant depression

Post published:September 9, 2021
Post category:Press Release

Read more about the article CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

CaaMTech Raises $22 Million for Psychedelic Drug Discovery and Development

Post published:September 8, 2021
Post category:Press Release

Read more about the article Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation Clerkenwell Health Partner to Bring Innovative Psychedelics to Patients

Danish Synthetic Biology Drug Developer Octarine and British Clinical Research Organisation Clerkenwell Health Partner to Bring Innovative Psychedelics to Patients

Post published:September 8, 2021
Post category:Press Release

Read more about the article Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1

Psyched Wellness Commences Neurobehavioral Preclinical Trial Study on AME-1

Post published:September 8, 2021
Post category:Press Release

Read more about the article PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021

PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021

Post published:September 8, 2021
Post category:Press Release

Read more about the article Danish And British Startups Partner to Bring Innovative Psychedelics to Patients

Danish And British Startups Partner to Bring Innovative Psychedelics to Patients

Post published:September 8, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.